Company Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories.
It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
| Country | United States |
| Founded | 2001 |
| IPO Date | Feb 14, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 753 |
| CEO | Kevin R. Smith |
Contact Details
Address: 500 Cummings Center, Suite 2800 Beverly, Massachusetts 01915 United States | |
| Phone | 805 562 0500 |
| Website | provider.inogen.com |
Stock Details
| Ticker Symbol | INGN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001294133 |
| CUSIP Number | 45780L104 |
| ISIN Number | US45780L1044 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. M. Smith | President, Chief Executive Officer and Director |
| Kevin P. Smith | General Counsel, Secretary and Executive Vice President of Business Development |
| Grgoire Ramade | Executive Vice President and Chief Commercial Officer |
| Michael J. Bourque CPA | Advisor |
| Jason A. Richardson | Chief Financial Officer, Executive Vice President and Treasurer |
| Philip Corrin | Senior Vice President of Operations and Supply Chain |
| Mary Wright | Vice President and Chief Accounting Officer |
| Naga Rameswamy | Chief Technology Officer |
| Lorna Williams | Senior Vice President of Investor Relations |
| Dominic Hulton | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 28, 2026 | ARS | Filing |
| Apr 28, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 17, 2026 | PRE 14A | Other preliminary proxy statements |
| Apr 6, 2026 | 8-K | Current Report |
| Mar 30, 2026 | 8-K | Current Report |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Feb 27, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Jan 12, 2026 | 8-K | Current Report |